Critical Outcome Technologies Completes Private Placement With a Successful U.S. Life Science Investor
Critical Outcome Technologies Set to Form JV with Portage Biotech Inc. for Clinical Development of COTI-2
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake